Anaplastic Malignant Neoplasm — Trials

Anaplastic Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,019 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 546
Recruiting: 290
Ph III recruiting: 18
Growth YoY: +34.5%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (324)

clinicaltrialsPublishedShowing 751–800 of 867 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01582516	Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma	completed	Phase 1 / Phase 2	20	Erasmus Medical CenterOTHER	1	Mar 9, 2015	clinicaltrials
NCT01198665	RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas(RADCHOP)	completed	Phase 1 / Phase 2	46	Samsung Medical CenterOTHER	1	Mar 3, 2015	clinicaltrials